-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The risk of being overweight or obese in patients during the COVID-19 pandemic has attracted widespread attention
.
Indeed, obesity is associated with respiratory insufficiency, which may be exacerbated by COVID-19 pneumonia or respiratory complications, which may increase the need for ventilatory support and length of hospital stay
The risk of being overweight or obese in patients during the COVID-19 pandemic has attracted widespread attention
This study included patients hospitalized with severe acute respiratory tract from January 2020 to January 2021, while excluding patients with a BMI below 10 kg/ m2 and above 100 kg/m2 , according to BMI was classified as underweight (BMI <18.
5), normal (BMI ≥18.
5 or 20.
5-24.
99), overweight (BMI 25.
00-29.
99) or obese (BMI ≥30) .
Time to in-hospital death was analyzed using competing risks regression .
A total of 12,137 patients (age 60.
0 ± 16.
2 years, 59% male, BMI 29.
2 diabetes
Figure: Association of Body Mass Index with COVID-19-Related Hospital Deaths
This study confirms that although body mass index is associated with COVID-19-related in-hospital deaths, it does not imply a change in the medical care of hospitalized patients, but clinically supports the use of BMI categories to stratify patients participating in intervention studies
.
.
Original source:
JasonBouzioti.
Association of body mass index with COVID-19 related in-hospital death Leave a message here
